David S. Burt

Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears β-amyloid in a mouse model of Alzheimer disease

Dan Frenkel, Ruth Maron, David S. Burt et al. · Journal of Clinical Investigation · 2005 · 166 citations · Full text

Immunology, Neuroinflammation, Alzheimer's Disease +18

Heterosubtypic Immunity against Human Influenza A Viruses, Including Recently Emerged Avian H5 and H9 Viruses, Induced by FLU–ISCOM Vaccine in Mice Requires both Cytotoxic T-Lymphocyte and Macrophage Function

Suryaprakash Sambhara, Anjna Kurichh, Renata Lima de Miranda et al. · Cellular Immunology · 2001 · 135 citations

Flu–iscom Vaccine, Immunology, Immunodominance +9

Augmentation of Human Influenza A Virus-Specific Cytotoxic T Lymphocyte Memory by Influenza Vaccine and Adjuvanted Carriers (ISCOMS)

Francis A. Ennis, John Cruz, Julie Jameson et al. · Virology · 1999 · 110 citations

Vaccination, Adjuvanted Carriers, Immunology +6

Skin mast cells in polycythaemia vera relationship to the pathogenesis and treatment of pruritus

Natalie Jackson, David S. Burt, J Crocker et al. · British Journal of Dermatology · 1987 · 80 citations

Mast Cell Disorder, Immunology, Skin Allergy +18

Intranasal Immunization with Multivalent Group A Streptococcal Vaccines Protects Mice against Intranasal Challenge Infections

Mary A. Hall, Steven D. Stroop, Mary C. Hu et al. · Infection and Immunity · 2004 · 77 citations · Full text

Vaccination, Hexavalent Protein, Mucosal Vaccination +12